1. Home
  2. Analysis
  3. Neurontin
  4. Complex-partial-seizures-exacerbated

Neurontin and Complex partial seizures exacerbated - a phase IV clinical study of FDA data

Summary:

Complex partial seizures exacerbated is reported as a side effect among people who take Neurontin (gabapentin), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Topamax, and have Epilepsy.

The phase IV clinical study analyzes which people have Complex partial seizures exacerbated when taking Neurontin. It is created by eHealthMe based on reports of 103,969 people who have side effects when taking Neurontin from the FDA, and is updated regularly.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.

What is Complex partial seizures exacerbated?

Complex partial seizures exacerbated (type of seizure in epilepsy) is found to be associated with 201 drugs and 247 conditions by eHealthMe. Check the latest studies of Complex partial seizures exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

103,969 people reported to have side effects when taking Neurontin.
Among them, 72 people (0.07%) have Complex partial seizures exacerbated.

Could Neurontin cause Complex partial seizures exacerbated?

Among these 72 people:

How long have people been on Neurontin when they have Complex partial seizures exacerbated? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 83.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Complex partial seizures exacerbated when taking Neurontin? *

  • female: 69.44 %
  • male: 30.56 %

What is the age of people who have Complex partial seizures exacerbated when taking Neurontin? *

  • 0-1: 0.0 %
  • 2-9: 5.08 %
  • 10-19: 6.78 %
  • 20-29: 8.47 %
  • 30-39: 22.03 %
  • 40-49: 32.2 %
  • 50-59: 16.95 %
  • 60+: 8.47 %

What are other drugs people take besides Neurontin? *

  1. Topamax: 13 people, 18.06%
  2. Carbamazepine: 11 people, 15.28%
  3. Dilantin: 10 people, 13.89%
  4. Plavix: 9 people, 12.50%
  5. Albuterol: 9 people, 12.50%
  6. Keppra: 9 people, 12.50%
  7. Depakote: 8 people, 11.11%
  8. Prednisone: 7 people, 9.72%
  9. Fosamax: 7 people, 9.72%
  10. Ms Contin: 7 people, 9.72%

What are other side effects people have besides Complex partial seizures exacerbated? *

  1. Fall: 17 people, 23.61%
  2. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 17 people, 23.61%
  3. Loss Of Consciousness: 11 people, 15.28%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 10 people, 13.89%
  5. Drug Ineffective: 10 people, 13.89%
  6. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 9 people, 12.50%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 9 people, 12.50%
  8. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 9 people, 12.50%
  9. Bone Density Decreased: 9 people, 12.50%
  10. Dehydration (dryness resulting from the removal of water): 8 people, 11.11%

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 15.28%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 8 people, 11.11%
  3. Osteoporosis (bones weak and more likely to break): 7 people, 9.72%
  4. Ill-Defined Disorder: 5 people, 6.94%
  5. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 5.56%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.56%
  7. Depression: 3 people, 4.17%
  8. Panic Disorder: 2 people, 2.78%
  9. Multiple Allergies (allergy to multiple agents): 2 people, 2.78%
  10. Agitation (state of anxiety or nervous excitement): 2 people, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and have Complex partial seizures exacerbated?

- Check whether Complex partial seizures exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neurontin:

Complex partial seizures exacerbated treatments and more:

How severe was Complex partial seizures exacerbated and when was it recovered:

Expand to all the drugs that have ingredients of gabapentin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Complex partial seizures exacerbated:

Browse all the conditions that are associated with Complex partial seizures exacerbated:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.